Overview and Highlights of the RESET Clinical Trial


Helen Thackray, MD, provides a brief overview and highlights of the RESET clinical trial.

In an interview with Pharmacy Times, Helen Thackray, MD from GlycoMimetics, Inc. gave a quick overview and highlights of her study, called “Early Initiation of Treatment with Rivipansel for Acute Vaso-Occlusive Crisis in Sickle Cell Disease (SCD) Achieves Earlier Discontinuation of IV Opioids and Shorter Hospital Stay: Reset Clinical Trial Analysis," which was presented at the 62nd ASH Annual Meeting and Exposition.

Related Videos
Young depressed woman talking to lady psychologist during session, mental health - Image credit: motortion | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.